Global Pneumococcal Conjugate Vaccine (PCV) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pneumococcal Conjugate Vaccine (PCV) Industry Forecast” looks at past sales and reviews total world Pneumococcal Conjugate Vaccine (PCV) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pneumococcal Conjugate Vaccine (PCV) sales for 2023 through 2029. With Pneumococcal Conjugate Vaccine (PCV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Conjugate Vaccine (PCV) industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Conjugate Vaccine (PCV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Conjugate Vaccine (PCV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Conjugate Vaccine (PCV) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Conjugate Vaccine (PCV) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Conjugate Vaccine (PCV).
The global Pneumococcal Conjugate Vaccine (PCV) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pneumococcal Conjugate Vaccine (PCV) players cover Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic and Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Conjugate Vaccine (PCV) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Pneumococcal Conjugate Vaccine (PCV) Industry Forecast” looks at past sales and reviews total world Pneumococcal Conjugate Vaccine (PCV) sales in 2022, providing a comprehensive analysis by region and market sector of projected Pneumococcal Conjugate Vaccine (PCV) sales for 2023 through 2029. With Pneumococcal Conjugate Vaccine (PCV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Conjugate Vaccine (PCV) industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Conjugate Vaccine (PCV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Conjugate Vaccine (PCV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pneumococcal Conjugate Vaccine (PCV) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Conjugate Vaccine (PCV) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Conjugate Vaccine (PCV).
The global Pneumococcal Conjugate Vaccine (PCV) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pneumococcal Conjugate Vaccine (PCV) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pneumococcal Conjugate Vaccine (PCV) players cover Pfizer, GSK, Sanofi, Merck, Walvax Biotechnology, Royal (Wuxi) Bio-Pharmaceutical, Zhifei Biologic and Serum Institute of India, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Conjugate Vaccine (PCV) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- 23-valent Vaccine
- 10-valent Vaccine
- 7-valent Vaccine
- 13-valent Vaccine
- Child
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- Sanofi
- Merck
- Walvax Biotechnology
- Royal (Wuxi) Bio-Pharmaceutical
- Zhifei Biologic
- Serum Institute of India
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2029
2.1.2 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Type
2.2.1 23-valent Vaccine
2.2.2 10-valent Vaccine
2.2.3 7-valent Vaccine
2.2.4 13-valent Vaccine
2.3 Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
2.3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
2.4 Pneumococcal Conjugate Vaccine (PCV) Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
2.5.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
3 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SIZE BY PLAYER
3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Players
3.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2018-2023)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2018-2023)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) BY REGIONS
4.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2018-2023)
4.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
5.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
5.3 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023)
6.2 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
6.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pneumococcal Conjugate Vaccine (PCV) by Country (2018-2023)
7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) by Region (2018-2023)
8.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
8.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET FORECAST
10.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2024-2029)
10.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2024-2029)
10.1.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast
10.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2024-2029)
10.2.1 United States Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.2 Canada Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.3 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.4 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2024-2029)
10.3.1 China Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.2 Japan Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.3 Korea Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.4 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.5 India Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.6 Australia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2024-2029)
10.4.1 Germany Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.2 France Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.3 UK Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.4 Italy Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.5 Russia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2024-2029)
10.5.1 Egypt Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.2 South Africa Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.4 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.5 GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.6 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Type (2024-2029)
10.7 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Information
11.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Walvax Biotechnology Main Business Overview
11.5.5 Walvax Biotechnology Latest Developments
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments
11.7 Zhifei Biologic
11.7.1 Zhifei Biologic Company Information
11.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Zhifei Biologic Main Business Overview
11.7.5 Zhifei Biologic Latest Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Information
11.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Serum Institute of India Main Business Overview
11.8.5 Serum Institute of India Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2029
2.1.2 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Type
2.2.1 23-valent Vaccine
2.2.2 10-valent Vaccine
2.2.3 7-valent Vaccine
2.2.4 13-valent Vaccine
2.3 Pneumococcal Conjugate Vaccine (PCV) Market Size by Type
2.3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
2.4 Pneumococcal Conjugate Vaccine (PCV) Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
2.5.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
3 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SIZE BY PLAYER
3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Players
3.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2018-2023)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2018-2023)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) BY REGIONS
4.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2018-2023)
4.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
4.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
5.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
5.3 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023)
6.2 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
6.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pneumococcal Conjugate Vaccine (PCV) by Country (2018-2023)
7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) by Region (2018-2023)
8.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023)
8.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET FORECAST
10.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2024-2029)
10.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2024-2029)
10.1.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast
10.1.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast
10.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2024-2029)
10.2.1 United States Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.2 Canada Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.3 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.2.4 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2024-2029)
10.3.1 China Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.2 Japan Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.3 Korea Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.4 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.5 India Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.3.6 Australia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2024-2029)
10.4.1 Germany Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.2 France Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.3 UK Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.4 Italy Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.4.5 Russia Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2024-2029)
10.5.1 Egypt Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.2 South Africa Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.4 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.5.5 GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Forecast
10.6 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Type (2024-2029)
10.7 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 GSK Main Business Overview
11.2.5 GSK Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Information
11.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Walvax Biotechnology Main Business Overview
11.5.5 Walvax Biotechnology Latest Developments
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments
11.7 Zhifei Biologic
11.7.1 Zhifei Biologic Company Information
11.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Zhifei Biologic Main Business Overview
11.7.5 Zhifei Biologic Latest Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Information
11.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered
11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Serum Institute of India Main Business Overview
11.8.5 Serum Institute of India Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 23-valent Vaccine
Table 3. Major Players of 10-valent Vaccine
Table 4. Major Players of 7-valent Vaccine
Table 5. Major Players of 13-valent Vaccine
Table 6. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 9. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player (2018-2023)
Table 14. Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered
Table 15. Pneumococcal Conjugate Vaccine (PCV) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2018-2023)
Table 20. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2018-2023)
Table 24. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 26. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 28. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Table 30. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 32. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 34. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2018-2023)
Table 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 38. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Pneumococcal Conjugate Vaccine (PCV)
Table 47. Key Market Challenges & Risks of Pneumococcal Conjugate Vaccine (PCV)
Table 48. Key Industry Trends of Pneumococcal Conjugate Vaccine (PCV)
Table 49. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 54. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 55. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. GSK Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 59. GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 60. GSK Main Business
Table 61. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Latest Developments
Table 63. Sanofi Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 64. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 65. Sanofi Main Business
Table 66. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi Latest Developments
Table 68. Merck Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 69. Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 70. Merck Main Business
Table 71. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Merck Latest Developments
Table 73. Walvax Biotechnology Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 74. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 75. Walvax Biotechnology Main Business
Table 76. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Walvax Biotechnology Latest Developments
Table 78. Royal (Wuxi) Bio-Pharmaceutical Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 79. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 80. Royal (Wuxi) Bio-Pharmaceutical Main Business
Table 81. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Royal (Wuxi) Bio-Pharmaceutical Latest Developments
Table 83. Zhifei Biologic Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 84. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 85. Zhifei Biologic Main Business
Table 86. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Zhifei Biologic Latest Developments
Table 88. Serum Institute of India Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 89. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 90. Serum Institute of India Main Business
Table 91. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Serum Institute of India Latest Developments
Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 23-valent Vaccine
Table 3. Major Players of 10-valent Vaccine
Table 4. Major Players of 7-valent Vaccine
Table 5. Major Players of 13-valent Vaccine
Table 6. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 9. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player (2018-2023)
Table 14. Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered
Table 15. Pneumococcal Conjugate Vaccine (PCV) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2018-2023)
Table 20. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2018-2023)
Table 24. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 26. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 28. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Table 30. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 32. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 34. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2018-2023)
Table 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 38. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Pneumococcal Conjugate Vaccine (PCV)
Table 47. Key Market Challenges & Risks of Pneumococcal Conjugate Vaccine (PCV)
Table 48. Key Industry Trends of Pneumococcal Conjugate Vaccine (PCV)
Table 49. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Pfizer Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 54. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 55. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. GSK Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 59. GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 60. GSK Main Business
Table 61. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Latest Developments
Table 63. Sanofi Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 64. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 65. Sanofi Main Business
Table 66. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi Latest Developments
Table 68. Merck Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 69. Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 70. Merck Main Business
Table 71. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Merck Latest Developments
Table 73. Walvax Biotechnology Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 74. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 75. Walvax Biotechnology Main Business
Table 76. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Walvax Biotechnology Latest Developments
Table 78. Royal (Wuxi) Bio-Pharmaceutical Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 79. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 80. Royal (Wuxi) Bio-Pharmaceutical Main Business
Table 81. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Royal (Wuxi) Bio-Pharmaceutical Latest Developments
Table 83. Zhifei Biologic Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 84. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 85. Zhifei Biologic Main Business
Table 86. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Zhifei Biologic Latest Developments
Table 88. Serum Institute of India Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors
Table 89. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered
Table 90. Serum Institute of India Main Business
Table 91. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Serum Institute of India Latest Developments
LIST OF FIGURES
Figure 1. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pneumococcal Conjugate Vaccine (PCV) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country/Region (2022)
Figure 8. Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2022
Figure 10. Pneumococcal Conjugate Vaccine (PCV) in Child
Figure 11. Global Pneumococcal Conjugate Vaccine (PCV) Market: Child (2018-2023) & ($ Millions)
Figure 12. Pneumococcal Conjugate Vaccine (PCV) in Adult
Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market: Adult (2018-2023) & ($ Millions)
Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2022
Figure 15. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player in 2022
Figure 16. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 18. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 19. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 21. Americas Pneumococcal Conjugate Vaccine (PCV) Value Market Share by Country in 2022
Figure 22. United States Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2022
Figure 27. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2022
Figure 28. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2022
Figure 29. China Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2022
Figure 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Figure 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Figure 38. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 52. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 53. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 55. United States Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 56. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 59. China Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 60. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 61. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 63. India Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 64. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 65. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 66. France Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 67. UK Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 68. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 69. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 70. Spain Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 73. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 76. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Pneumococcal Conjugate Vaccine (PCV) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country/Region (2022)
Figure 8. Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2022
Figure 10. Pneumococcal Conjugate Vaccine (PCV) in Child
Figure 11. Global Pneumococcal Conjugate Vaccine (PCV) Market: Child (2018-2023) & ($ Millions)
Figure 12. Pneumococcal Conjugate Vaccine (PCV) in Adult
Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market: Adult (2018-2023) & ($ Millions)
Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2022
Figure 15. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player in 2022
Figure 16. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 18. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 19. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2018-2023 ($ Millions)
Figure 21. Americas Pneumococcal Conjugate Vaccine (PCV) Value Market Share by Country in 2022
Figure 22. United States Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2022
Figure 27. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2022
Figure 28. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2022
Figure 29. China Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2022
Figure 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Figure 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Figure 38. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 52. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 53. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 55. United States Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 56. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 59. China Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 60. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 61. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 63. India Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 64. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 65. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 66. France Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 67. UK Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 68. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 69. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 70. Spain Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 73. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Size 2024-2029 ($ Millions)
Figure 76. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Application (2024-2029)
